Emicizumab is a bispecific antibody with 2 binding sites, 1 each for activated FIX (FIXa) and FX, bringing them together in a way that mimics the role of missing FVIIIa in hemophilia A. https://t.co/YDFpirU2zO https://t.co/nSamF69fIk
15,125 followers
1,158 followers
RT @StanfordChiefs: 2) In hemophilia A, we can bypass factor VIII by using emicizumab, which binds the active factor IX to factor X, and le…
1,918 followers
2) In hemophilia A, we can bypass factor VIII by using emicizumab, which binds the active factor IX to factor X, and lets factor IXa activate factor X directly! This can potentially reduce the amount of recombinant factor VIII you need to give. [2/4] https
648 followers
RT @ProfMakris: Another #emicizumab (#Hemlibra) review with free PDF. The top right hand cell of table 1 is the most interesting for me. Wi…